MR-Linac Consortium:
Progress through
collaboration

The MR-Linac Consortium (the Consortium) is a collaborative platform intended to facilitate an evidence-based introduction of MRgRT and to develop and share best practices for an optimized radiation treatment approach to improve patient outcomes.

Achieving this goal is a collaboration between industry and academia. Both parties have a mutual interest in the capabilities of Unity being developed to maximize the clinical impact and the generation of high-quality evidence to demonstrate that impact. Clinical activities and publications within the Consortium are driven by participating sites and individual users. MR-Linac Consortium facilitates this clinical work by providing a platform in terms of organizational support, technical solutions and appropriate funding.